Phase II Evaluation of Exhaled Nitric Oxide (NO)

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Lung Cancer
Interventions
PROCEDURE

Nitric oxide breath test

Breathe out into a device (nitric oxide breath analyzer) for 10 seconds; repeated 3 times. Done prior to start of radiation therapy, 1 week before completion of radiation therapy, at completion of radiation therapy, then at each follow-up visit for 6 months.

BEHAVIORAL

Questionnaires

On day of each breathing test, completion of a breathing and symptom questionnaire, approximately 10 minutes.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT01392144 - Phase II Evaluation of Exhaled Nitric Oxide (NO) | Biotech Hunter | Biotech Hunter